Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 2
2001 1
2004 1
2005 1
2007 1
2010 1
2018 2
2019 3
2020 1
2021 4
2022 3
2023 3
2024 2
2025 4
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study.
Mocci G, Tursi A, Scaldaferri F, Napolitano D, Pugliese D, Maconi G, Cataletti G, Pica R, Cassieri C, Savarino EV, De Barba C, Costa F, Ceccarelli L, Marzo M, Elisei W, Monterubbianesi R, Faggiani R, Lombardi G, Patturelli M, Ribaldone DG, Bertani L, Rodinò S, Sebkova L, Bodini G, Pasta A, Pranzo G, Serio M, Scarcelli A, Luppino I, Ferronato A, Spagnuolo R, Luzza F, Gravina AG, Pellegrino R, Vespere G, Sedda S, D'Onofrio V, De Luca L, Allegretta L, Cazzato AI, Fanigliuolo L, Grossi L, Cortellini F, Forti G, Tonti P, Neve V, Piergallini S, Di Fonzo M, Iacopini F, Capone P, Gaiani F, Kayali S, Mucherino C, D'Antonio E, Montesano L, Cocco A, D'Ascoli B, Colucci R, Bachetti F, Orrù G, Onidi FM, Usai Satta P, Picchio M, Papa A. Mocci G, et al. Among authors: sebkova l. J Clin Med. 2025 Nov 3;14(21):7801. doi: 10.3390/jcm14217801. J Clin Med. 2025. PMID: 41227197 Free PMC article.
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study.
Mocci G, Tursi A, Scaldaferri F, Napolitano D, Pugliese D, Capobianco I, Bartocci B, Blasi V, Savarino EV, Maniero D, Redavid C, Lorenzon G, Cuomo A, Donnarumma L, Gravina AG, Pellegrino R, Bodini G, Pasta A, Marzo M, Serio M, Scarcelli A, Rodinò S, Sebkova L, Maconi G, Cataletti G, Luppino I, Checchin D, Ferronato A, Gaiani F, Kayali S, Felice C, Pranzo G, Catarella D, D'Agostino D, Di Bartolo E, Lombardi G, Patturelli M, Bendia E, Bolognini L, Balducci D, Quatraccioni C, Martini F, Mucherino C, D'Antonio E, Montesano L, Vespere G, Sedda S, D'Onofrio V, De Luca L, Spagnuolo R, Luzza F, Fanigliulo L, Rocco G, Sacchi C, Zampaletta C, Grossi L, Lorenzetti R, Aragona G, Perazzo P, Forti G, Allegretta L, Cazzato AI, Scorza S, Cortellini F, Capone P, Villani GD, Di Fonzo M, Iacopini F, Tonti P, Neve V, Colucci R, Elisei W, Monterubbianesi R, Faggiani R, Pica R, Pagnini C, Graziani MG, Di Paolo MC, Onidi FM, Saba F, Dore MP, Usai-Satta P, Picchio M, Papa A. Mocci G, et al. Among authors: sebkova l. J Clin Med. 2024 Nov 27;13(23):7192. doi: 10.3390/jcm13237192. J Clin Med. 2024. PMID: 39685651 Free PMC article.
Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study.
Tursi A, Pasta A, Elisei W, Barberio B, Mocci G, Savarino EV, de Barba C, Maconi G, Cataletti G, Scaldaferri F, Napolitano D, Costa F, Ceccarelli L, Marzo M, Monterubbianesi R, di Fonzo M, Lombardi G, Patturelli M, Ribaldone DG, Bertani L, Rodino' S, Sebkova L, Bodini G, Pranzo G, Serio M, Scarcelli A, Luppino I, Ferronato A, Spagnuolo R, Luzza F, Morano D, Gravina AG, Pellegrino R, Vespere G, Sedda S, Allegretta L, Fanigliulo L, Grossi L, Cortellini F, Forti G, Neve V, Piergallini S, Scarozza P, Bevevino G, Iacopini F, Capone P, Gaiani F, Kayali S, Mucherino C, D'antonio E, D'ascoli B, Colucci R, Bachetti F, Giorgetti GM, Clemente V, Pagnini C, Cuomo A, Donnarumma L, Onidi FM, Satta PU, Picchio M, Papa A; Italian Network for Inflammatory Bowel Diseases (IN-IBD). Tursi A, et al. Among authors: sebkova l. Adv Ther. 2026 Jul;43(7):3165-3186. doi: 10.1007/s12325-026-03622-3. Epub 2026 May 9. Adv Ther. 2026. PMID: 42105145 Free PMC article.
Real‑world safety and efficacy of biological agents in inflammatory bowel disease: a one-year post-marketing pharmacovigilance observational study in the Calabria region.
Fabiano A, De Sarro C, Frajia D, Bosco F, Guarnieri L, Ruga S, Rodinò S, Sebkova L, Ciliberto E, Buoncompagni I, Costantino L, Leo A, Marcianò G, Rania V, Citraro R, Michael A, De Sarro G. Fabiano A, et al. Among authors: sebkova l. Pharmacol Rep. 2025 Oct;77(5):1415-1427. doi: 10.1007/s43440-025-00774-x. Epub 2025 Aug 19. Pharmacol Rep. 2025. PMID: 40828456 Free PMC article.
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study.
Tursi A, Mocci G, Costa F, Ceccarelli L, Savarino E, De Barba C, Mucherino C, D'Antonio E, Montesano L, Marzo M, Scaldaferri F, Napolitano D, Pugliese D, Gravina AG, Pellegrino R, Spagnuolo R, Luzza F, Cuomo A, Donnarumma L, Maconi G, Cataletti G, Bertani L, Bodini G, Pasta A, Piergallini S, Serio M, Scarcelli A, Capone P, Cortellini F, Rodino S, Sebkova L, Vespere G, Sedda S, D'Onofrio V, De Luca L, Gaiani F, Kayali S, Pagnini C, Graziani MG, Di Paolo MC, Allegretta L, Cazzato AI, Scorza S, Ferronato A, Ribaldone DG, Aragona G, Perazzo P, Forti G, Di Fonzo M, Iacopini F, Pica R, Cassieri C, Onidi FM, Usai Satta P, Elisei W, Picchio M, Papa A. Tursi A, et al. Among authors: sebkova l. Intest Res. 2026 Apr;24(2):341-351. doi: 10.5217/ir.2025.00067. Epub 2025 Sep 29. Intest Res. 2026. PMID: 41017298 Free PMC article.
Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study.
Tursi A, Mocci G, Scaldaferri F, Napolitano D, Gaiani F, De' Angelis G, Ribaldone DG, Schillaci E, Savarino EV, Barba CDE, Bendia E, Bolognini L, Balducci D, Quatraccioni C, Martini F, Montori M, Giovanni Maconi, Cataletti G, Massari A, Del Zanna E, Costa F, Ceccarelli L, Gravina AG, Pellegrino R, Bodini G, Pasta A, Marzo M, Miranda A, Cuomo A, Donnarumma L, Lombardi G, Patturelli M, Serio M, Antonella Scarcelli, Pranzo G, Chiara Maria Palmisano, Rocco Spagnuolo, Luzza F, Morano D, Vespere G, Sedda S, Luca LDE, Elisei W, Monterubbianesi R, Di Fonzo M, Fanigliulo L, Pica R, Cassieri C, Cocco A, Stasi E, Grossi L, Bertani L, Cortellini F, Piergallini S, Scarozza P, Bevevino G, Zerboni G, Iacopini F, Rodino' S, Sebkova L, Checchin D, Lamboglia F, Ferrara F, Della Valle N, Colucci R, Bachetti F, Catarella D, D'agostino D, Bartolo EDI, Luppino I, Erboso M, Rocco G, Sacchi C, Zampaletta C, Giacomo Forti, Fiorella S, Bassotti G, Antonelli E, Mucherino C, D'Antonio E, Montesano L, Giovannone M, Vincoli G, Gigliozzi A, D'Ascoli B, Rizzi M, Capone P, Aragona G, Perazzo P, Allegretta L, Tonti P, Neve V, Pagnini C, Grandolfo A, Gatti F, Bucci A, Rizzi M, Picchio M, Onidi FM, Usai Satta… See abstract for full author list ➔ Tursi A, et al. Among authors: sebkova l. Am J Ther. 2026 Sep-Oct 01;33(5):e363-e372. doi: 10.1097/MJT.0000000000002171. Epub 2026 Jul 23. Am J Ther. 2026. PMID: 42490306 Free PMC article.
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study.
Tursi A, Mocci G, Scaldaferri F, Napolitano D, Maresca R, Pugliese D, Semprucci G, Savarino E, Cuomo A, Donnarumma L, Bodini G, Pasta A, Maconi G, Cataletti G, Pranzo G, Rodinò S, Sebkova L, Costa F, Ferronato A, Gaiani F, Marzo M, Luppino I, Fabiano G, Paese P, Elisei W, Monterubbianesi R, Faggiani R, Grossi L, Serio M, Scarcelli A, Lorenzetti R, Allegretta L, Chiri S, Grasso G, Antonelli E, Bassotti G, Spagnuolo R, Luzza F, Fanigliulo L, Rocco G, Sacchi C, Zampaletta C, Rocchi C, Bolognini L, Bendia E, Bianco MA, Capone P, Meucci C, Colucci R, Tonti P, Neve V, Della Valle N, Felice C, Pica R, Cocco A, Forti G, Onidi FM, Usai Satta P, Checchin D, Gravina AG, Pellegrino R, Picchio M, Papa A. Tursi A, et al. Among authors: sebkova l. Expert Opin Biol Ther. 2024 Jan-Feb;24(1-2):101-109. doi: 10.1080/14712598.2024.2309300. Epub 2024 Jan 25. Expert Opin Biol Ther. 2024. PMID: 38250818
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study.
Tursi A, Mocci G, Cingolani L, Savarino E, Pica R, Cocco A, Zippi M, Napolitano D, Schiavoni E, Pugliese D, Scaldaferri F, Costa F, Marzo M, Serio M, Scarcelli A, Bolognini L, Bendia E, Maconi G, Cannatelli R, Piergallini S, Bodini G, Calabrese F, Ferronato A, Pranzo G, Elisei W, Monterubbianesi R, Faggiani R, Rodinò S, Sebkova L, Grossi L, Gaiani F, Dè Angelis G, Lorenzetti R, Allegretta L, Cazzato AI, Scorza S, Della Valle N, Sacco R, Forti G, Colucci R, Tonti P, Neve V, Rocco G, Sacchi C, Zampaletta C, Pagnini C, Graziani MG, Di Paolo MC, Onidi FM, Usai Satta P, Picchio M, Papa A. Tursi A, et al. Among authors: sebkova l. Expert Opin Pharmacother. 2023 Sep-Dec;24(14):1649-1656. doi: 10.1080/14656566.2023.2230126. Epub 2023 Jun 28. Expert Opin Pharmacother. 2023. PMID: 37358928
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study.
Tursi A, Mocci G, Allegretta L, Aragona G, Bianco MA, Colucci R, Cuomo A, Della Valle N, Ferronato A, Forti G, Gaiani F, Giorgetti G, Graziani MG, Lofano K, Lorenzetti R, Larussa T, Penna A, Pica R, Pranzo G, Rodino' S, Scarcelli A, Zampaletta C, Bassotti G, Cazzato AI, Chiri S, Clemente V, Cocco A, De' Angelis G, Donnarumma L, Faggiani R, Graziosi C, Le Grazie M, Luzza F, Meucci C, Monterubbianesi R, Pagnini C, Perazzo P, Picchio M, Sacco R, Sebkova L, Serio M, Napolitano D, Pugliese D, Scaldaferri F, Schiavoni E, Turchini L, Armuzzi A, Elisei W, Maconi G, Papa A. Tursi A, et al. Among authors: sebkova l. Inflamm Bowel Dis. 2023 Mar 1;29(3):376-383. doi: 10.1093/ibd/izac092. Inflamm Bowel Dis. 2023. PMID: 35579320 Free article.
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study.
Mocci G, Tursi A, Maconi G, Cataletti G, Mantia B, Serio M, Scarcelli A, Pagnini C, Graziani MG, Di Paolo MC, Pranzo G, Luppino I, Paese P, Elisei W, Monterubbianesi R, Faggiani R, Ferronato A, Perini B, Savarino E, Onidi FM, Binaghi L, Usai Satta P, Schiavoni E, Napolitano D, Scaldaferri F, Pugliese D, Pica R, Cocco A, Zippi M, Rodino S, Sebkova L, Rocco G, Sacchi C, Zampaletta C, Gaiani F, De Angelis G, Kayali S, Fanigliulo L, Lorenzetti R, Allegretta L, Scorza S, Cuomo A, Donnarumma L, Della Valle N, Sacco R, Forti G, Antonelli E, Bassotti G, Iannelli C, Luzza F, Aragona G, Perazzo P, Lauria A, Piergallini S, Colucci R, Bianco MA, Meucci C, Giorgetti G, Clemente V, Fiorella S, Penna A, De Medici A, Picchio M, Papa A. Mocci G, et al. Among authors: sebkova l. Expert Opin Biol Ther. 2023 Mar;23(3):293-304. doi: 10.1080/14712598.2023.2185510. Epub 2023 Mar 2. Expert Opin Biol Ther. 2023. PMID: 36843568
30 results